Skip to main content
logo
Seaport Therapeutics, Inc. (SPTX)
Seaport Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

Seaport Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
Dec '25 Dec '24
Net Income
-74.88-46.88
Depreciation & Amortization
-2.030.21
Share-Based Compensation
6.8814.52
Other Operating Activities
-7.922.51
Operating Cash Flow
-77.94-29.63
Capital Expenditures
-0.36-0.11
Change in Investments
-183.89-
Investing Cash Flow
-184.25-0.11
Share Issuance / Repurchase
0325.33
Other Financing Activities
-0.8713.97
Financing Cash Flow
-0.87339.3
Net Cash Flow
-263.06309.55
Free Cash Flow
-78.3-29.74
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).